WO1998057981A3 - Chlamydia pneumoniae specific peptides and their use in diagnostic assays - Google Patents

Chlamydia pneumoniae specific peptides and their use in diagnostic assays Download PDF

Info

Publication number
WO1998057981A3
WO1998057981A3 PCT/IL1998/000277 IL9800277W WO9857981A3 WO 1998057981 A3 WO1998057981 A3 WO 1998057981A3 IL 9800277 W IL9800277 W IL 9800277W WO 9857981 A3 WO9857981 A3 WO 9857981A3
Authority
WO
WIPO (PCT)
Prior art keywords
diagnostic assays
chlamydia pneumoniae
specific peptides
pneumoniae specific
pneumoniae
Prior art date
Application number
PCT/IL1998/000277
Other languages
French (fr)
Other versions
WO1998057981A2 (en
Inventor
Bella Ohana
Original Assignee
Savyon Diagnostics Ltd
Bella Ohana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savyon Diagnostics Ltd, Bella Ohana filed Critical Savyon Diagnostics Ltd
Priority to EP98925909A priority Critical patent/EP1012182A2/en
Priority to AU77862/98A priority patent/AU7786298A/en
Priority to IL13355798A priority patent/IL133557A0/en
Publication of WO1998057981A2 publication Critical patent/WO1998057981A2/en
Publication of WO1998057981A3 publication Critical patent/WO1998057981A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A peptide derived from the variable domain of C. pneumoniae MOMP protein, for use in the diagnosis of C. pneumoniae infections, said peptide comprises between 9-40 amino acids and being able to react with antibodies formed during infection with C. pneumonia, further characterized by having essentially very low cross-reactivity towards antibodies against other Chlamydia species.
PCT/IL1998/000277 1997-06-19 1998-06-15 Chlamydia pneumoniae specific peptides and their use in diagnostic assays WO1998057981A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP98925909A EP1012182A2 (en) 1997-06-19 1998-06-15 Chlamydia pneumoniae specific peptides and their use in diagnostic assays
AU77862/98A AU7786298A (en) 1997-06-19 1998-06-15 (c. pneumoniae) specific peptides and their use in diagnostic assays
IL13355798A IL133557A0 (en) 1997-06-19 1998-06-15 C. pneumoniae specific peptides and their use in diagnostic assays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12111497A IL121114A (en) 1997-06-19 1997-06-19 C pneumoniae specific peptides and their use in diagnostic assays
IL121114 1997-06-19

Publications (2)

Publication Number Publication Date
WO1998057981A2 WO1998057981A2 (en) 1998-12-23
WO1998057981A3 true WO1998057981A3 (en) 1999-03-11

Family

ID=11070277

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL1998/000277 WO1998057981A2 (en) 1997-06-19 1998-06-15 Chlamydia pneumoniae specific peptides and their use in diagnostic assays

Country Status (4)

Country Link
EP (1) EP1012182A2 (en)
AU (1) AU7786298A (en)
IL (1) IL121114A (en)
WO (1) WO1998057981A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011998A1 (en) * 1993-10-26 1995-05-04 United Biomedical, Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
WO1996007910A1 (en) * 1994-09-02 1996-03-14 Meiji Milk Products Company Limited Diagnostic drug for chlamydia infection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011998A1 (en) * 1993-10-26 1995-05-04 United Biomedical, Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
WO1996007910A1 (en) * 1994-09-02 1996-03-14 Meiji Milk Products Company Limited Diagnostic drug for chlamydia infection

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GAYDOS CA ET AL: "Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene.", INFECT IMMUN, DEC 1992, 60 (12) P5319-23, UNITED STATES, XP002084254 *
JANTOS CA ET AL: "Antigenic and molecular analyses of different Chlamydia pneumoniae strains.", J CLIN MICROBIOL, MAR 1997, 35 (3) P620-3, UNITED STATES, XP002084255 *
PEELING RW ET AL: "Chlamydiae as pathogens: new species and new issues.", EMERG INFECT DIS, OCT-DEC 1996, 2 (4) P307-19, UNITED STATES, XP002084256 *
PETERSON EM ET AL: "Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae.", INFECT IMMUN, AUG 1996, 64 (8) P3354-9, UNITED STATES, XP002084253 *
US DEPT HEALTH & HUMAN SERVICE, NTIS APPLICATION NUMBER US7324664, 29 September 1989 (1989-09-29), XP002085084 *

Also Published As

Publication number Publication date
AU7786298A (en) 1999-01-04
IL121114A0 (en) 1997-11-20
WO1998057981A2 (en) 1998-12-23
IL121114A (en) 2001-03-19
EP1012182A2 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
EP2287199A3 (en) Anti-alpha V beta 6 antibodies
CA2054798A1 (en) Hcv-specific peptides, agents therefor and the use thereof
WO2004041865A3 (en) Stabilized single domain antibodies
WO2000053722A3 (en) Delivery of nucleic acids and proteins to cells
EP2258725A3 (en) Cytokine receptor zcytor17
WO1999003881A3 (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
AU3667399A (en) Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
CA2129747A1 (en) Peptide for diagnosing and immunizing against t. cruzi infection
CA2328805A1 (en) Enzyme-protein complex
AU2002223044A1 (en) Kit and method for detecting the esm-1 protein
EP0840126A3 (en) Marker and immunological reagent for dialysis-related amyloidosis, diabetes mellitus and diabetes mellitus complications
CA2213798A1 (en) Method for stimulating an immune response
AU7960600A (en) Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
WO2003027149A1 (en) Antibody and use of the same
NZ336781A (en) Fibronectin binding protein compositions, antibodies thereto, and methods of use
EP0699688A3 (en) Chlamydia pneumoniae specific monoclonal antibodies and their diagnostic use
AU1880995A (en) Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents
WO1998057981A3 (en) Chlamydia pneumoniae specific peptides and their use in diagnostic assays
AU638155B2 (en) Peptides with a characteristic antigenic determinant for alphal-microglobulin
CA2303421A1 (en) Beta-defensins
AU3455693A (en) Peptides of the casein macropeptide, antibodies directed against said peptides, and applications
CA2128833A1 (en) P53as protein and antibody therefor
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
EP0915158A3 (en) Improvements in or relating to detection of salmonella
CA2140091A1 (en) Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 133557

Country of ref document: IL

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998925909

Country of ref document: EP

Ref document number: 09471811

Country of ref document: US

NENP Non-entry into the national phase

Ref document number: 1999504077

Country of ref document: JP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1998925909

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1998925909

Country of ref document: EP